Dianthus Therapeutics, Inc.
DNTH
$43.97
$1.694.00%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -36.77M | -31.63M | -29.51M | -28.44M | -25.17M |
| Total Depreciation and Amortization | 99.00K | 99.00K | 133.00K | 78.00K | 116.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.26M | 4.59M | 3.41M | 1.34M | 1.19M |
| Change in Net Operating Assets | 2.86M | 3.05M | -1.66M | -422.00K | 2.60M |
| Cash from Operations | -30.56M | -23.89M | -27.63M | -27.44M | -21.27M |
| Capital Expenditure | -5.00K | -46.00K | -24.00K | -31.00K | -25.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -201.27M | 26.49M | 14.82M | -23.08M | -259.34M |
| Cash from Investing | -201.28M | 26.45M | 14.79M | -23.11M | -259.36M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 274.69M | 568.00K | 161.00K | 39.68M | 296.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -172.00K | -- | -- | 0.00 | 0.00 |
| Cash from Financing | 274.51M | 568.00K | 161.00K | 39.68M | 296.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 42.68M | 3.12M | -12.68M | -10.88M | -280.34M |